Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
INHERET, Inc. logo — INHERET reduces the barriers physicians face in identifying...

INHERET, Inc.

INHERET reduces the barriers physicians face in identifying patients who may be at increased risk for hereditary disease

Founded 2018 United States Ann Arbor, United States 3 employees Seed Total: $3.18M Health Care, IT +1

General Information

Company Name INHERET, Inc.
Founded Year 2018
Location United States Ann Arbor, United States +1
Employees 3
Industries Health Care, IT, Information Technology
Funding Stage Seed
Social

Get notified when INHERET, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About INHERET, Inc.

INHERET, Inc. is a Health Care and Information Technology startup based in the United States. Founded in 2018, the company aims to reduce the barriers physicians face in identifying patients at increased risk for hereditary diseases. With the slogan "INHERET reduces the barriers physicians face in identifying patients who may be at increased risk for hereditary disease," the company provides Comprehensive Risk Assessment with a Personalized Approach, evaluating family health histories, and offering personalized risk reduction strategies for individuals. Recently, on 02 May 2022, the company secured a $580.00K Seed Round investment from the Accelerate Blue Fund. With its mission to improve hereditary disease identification and prevention, INHERET, Inc. is poised to make a significant impact in the healthcare industry with its innovative approach.

Taxonomy: personalized medicine, hereditary disease, risk assessment, physician support, patient risk identification, preventive healthcare, family health history, cancer risk assessment, early detection, healthcare analytics, clinical decision support, patient education, genetic risk evaluation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
02 May 2022
Grant •••••• 1 •••• •••• 18 Sep 2020

INHERET, Inc. Alternatives & Competitors

INHERET, Inc. vs
Presaj
Presaj United States

Focusing attention to prevent complications

Grant
2 employees
AI, Health Care
INHERET, Inc. vs
Kinometrix
Kinometrix United States

Precision Patient Safety Platform

Seed
2 employees
AI, Health Care
INHERET, Inc. vs
Phenogen Sciences
Phenogen Sciences

Empowering physicians with predictive risk assessments for proactive health management through clini...

Biotechnology, Health Care

FAQ About INHERET, Inc.

INHERET reduces the barriers physicians face in identifying patients who may be at increased risk for hereditary disease
INHERET, Inc. was founded in 2018.
INHERET, Inc. is headquartered in Ann Arbor, United States.
INHERET, Inc. operates in the following industries: Health Care, IT, Information Technology.
INHERET, Inc. has approximately 3 employees.
INHERET, Inc. has completed 2 funding rounds, raising a total of $3.18M. The latest funding stage is Seed.
Top alternatives and competitors to INHERET, Inc. include Presaj, Kinometrix, Phenogen Sciences, Preverity Inc, TIIM Healthcare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
INHERET, Inc. and Presaj are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors INHERET, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy